Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).

European journal of medical research

Volumn 7, Issue 1, 2002, Pages 1-7

  Baumgarten, Claus ^a   Geldszus, R ^a   Behre, U ^a   Peslis, N ^a   Trautmann, M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; ANTIASTHMATIC AGENT; DRUG DERIVATIVE; FLUTICASONE; SALBUTAMOL; SALMETEROL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PROSPECTIVE STUDY; SAFETY;

ADOLESCENT; ADULT; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG COMBINATIONS; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; SAFETY;

EID: 0037192356     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)